Enovis CORP (New York Stock Exchange:ENOV)
| Market Cap | $1.60B-7.7% |
| Revenue (ttm) | $2.31B+3.3% |
| Net Income | -$527.40M+61.4% |
| EPS | -$9.28+60.9% |
| Shares Out | 57.69M |
| PE Ratio | n/a |
| Forward PE | 7.99 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,198,004 |
| Open | $28.11 |
| Previous Close | $27.64 |
| Day's Range | $27.64 - $28.89 |
| 52-Week Range | $16.70 - $31.67 |
| Beta | 1.42 |
| Analysts | Buy |
| Price Target | $37.33(+34.86%) |
| Earnings Date | Feb 25, 2027 |
About ENOV
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Enovis CORP Stock Analysis — InsiderScore
Enovis CORP scored higher than 97% of companies evaluated by InsiderBuying, and ranked 1st out of 48 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Enovis CORP bought $599.5K of stock across 10 purchases in the last 90 days, the largest of them $249.6K.
The average purchase added about 3% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
7 firms rating ENOV in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 25, 2027Earnings report
$ENOV stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ENOV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ENOV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ENOV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ENOV Revenue by Segment or Geography
As of: Q4 2026 (Oct 2, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ENOV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ENOV from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ENOV
| IJRiShares Core S&P Small-Cap ETF | $99.63M |
| AVUVAvantis U.S. Small Cap Value ETF | $66.38M |
| IWMiShares Russell 2000 ETF | $42.67M |
| VTIVanguard Morningstar Total Stock Market ETF | $31.78M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $26.29M |
| VBVanguard Morningstar Small-Cap ETF | $22.54M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from ENOV’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat with raised full-year guidance and 5% organic growth drove positive coverage; multiple sources highlighted share price appreciation.
Recent Insider Activity
Insider Score Trend Over Time
+15.9 since Sep 16Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| XHE | State Street SPDR S&P Health Care Equipment ETF | 2.20% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 0.87% |
| ACSV | American Century ETF Trust - American Century Small Cap Value Insights ETF | 0.61% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.44% |
| ESSC | Eventide Small Cap ETF | 0.33% |
| ISMD | Inspire Small/Mid Cap ETF | 0.31% |
| BSVO | EA Bridgeway Omni Small-Cap Value ETF | 0.26% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.21% |
| AVUV | Avantis U.S. Small Cap Value ETF | 0.21% |
| IHI | iShares U.S. Medical Devices ETF | 0.20% |
| SMLV | State Street SPDR US Small Cap Low Volatility Index ETF | 0.19% |
| RUSC | Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF | 0.18% |
Weight is the stock’s share of each fund’s holdings.